 REHOVOT, Israel, Feb. 11, 2021 GLOBE NEWSWIRE -- CollPlant Biotechnologies NASDAQ:CLGN, today announced that it has entered into definitive agreements with several healthcare-focused and other institutional investors for the purchase and sale of 2,000,000 of the Companys American Depositary Shares ADSs, at a purchase price of 17.50 per ADS, in a registered direct offering. Each ADS represents one 1 ordinary share, par value NIS 1.50 per share, of CollPlant. The offering is expected to close on or about February 17, 2021, subject to satisfaction of customary closing conditions. 